#Switzerland #Zurich #LifeSphere #ArisGlobal #NavaX Insights

ArisGlobal Launches Innovative Solutions at Breakthrough 2025

On March 19, 2025, ArisGlobal, a renowned tech leader in life sciences, made headlines during its Breakthrough 2025 event held in Zurich, Switzerland. The company unveiled three advanced products aimed at transforming the landscape of pharmacovigilance and regulatory operations: LifeSphere Unify, NavaX Insights, and Advanced Compliance Docs.

LifeSphere Unify - A Comprehensive RD Compliance Platform

LifeSphere Unify is designed to integrate safety, medical affairs, regulatory, and quality data into a single platform. This innovative solution enhances organizational efficiency and ensures compliance while fostering innovation. With the power of NavaX, the Unify Platform promises faster market entry for new treatments. It achieves this by providing data-driven insights and unmatched interoperability across various domains. Moreover, it ensures scalable and secure operations, allowing organizations to navigate the complexities of life sciences more smoothly.

NavaX Insights - Real-Time Intelligence Redefined

NavaX Insights represents a groundbreaking enhancement in ArisGlobal’s offerings. This tool utilizes Agentic AI to automatically source, synthesize, and contextualize both proprietary and public information. Organizations can expect to benefit from:

• - Anticipating emerging risks and regulatory challenges proactively.
• - Uncovering hidden patterns and relationships that traditional analytical methods might overlook.
• - Facilitating quicker and more informed decision-making in pharmacovigilance and regulatory matters.
• - Transitioning from standard reporting to actionable contextual intelligence that drives strategic advantages.

This capability sets a new standard for data intelligence in life sciences, enabling organizations to work smarter and faster.

Advanced Compliance Docs - Streamlining Document Management

ArisGlobal's Advanced Compliance Docs further advances the automation of compliance processes. It offers intelligent, cloud-based document management that revolutionizes how Pharmacovigilance System Master Files (PSMFs) and Pharmacovigilance Agreements (PVAs) are created, stored, and managed. Key features include:

• - Automated document management with customizable, auto-populated templates for safety, regulatory, and clinical data.
• - Assurance of regulatory compliance while maintaining inspection readiness in light of evolving industry standards.
• - Speedy retrieval of critical PV documents housed in a centralized, user-friendly repository.
• - Enhanced collaboration through secure and audit-ready workflows that expedite approvals and mitigate compliance risks.

Ann-Marie Orange, CIO and Global Head of RD at ArisGlobal, expressed enthusiasm about these launches, emphasizing the significant strides ArisGlobal is making by leveraging the latest AI technologies. “We’re excited about the value our offerings bring in terms of data sharing and interoperability. These innovations empower organizations to connect insights seamlessly across their ecosystems,” she noted.

A Commitment to Ethical AI

ArisGlobal’s dedication to responsible AI use is further emphasized by its recent signing of the EU AI Pact, which aligns with global best practices for ethical AI implementation in the life sciences sector. This commitment underscores the company's focus on blending innovation with integrity while consistently prioritizing consumer safety and regulatory compliance.

As industry executives and leaders convened at Breakthrough 2025 under the theme AI in Action, they were privy to a demonstration of how these advanced technologies can be applied in real-world settings.

For further details on the revolutionary products and their implications for the life sciences industry, please visit ArisGlobal's website or follow them on LinkedIn for the latest updates.

About ArisGlobal

Founded in the United States, ArisGlobal is at the forefront of developing technologies that drive breakthroughs in the life sciences domain. With regional offices in Europe, India, Japan, and China, they continue to evolve the landscape for successful life sciences companies aiming to bring innovative products to market efficiently.